Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 1 hour 5 min ago

Instrument Trays Made of Solvay's Radel(R) PPSU Show Strong Compatibility with TSO3's Low-Temperature Sterilization System

Wed, 02/11/2015 - 12:44
ANAHEIM, CA and QUEBEC, Feb. 11, 2015 (Healthcare Sales & Marketing Network) - Solvay, a leading global supplier of high-performance thermoplastics, and TSO3 Inc., a leading developer of low-temperature sterilization systems for the healthcare industry, jo...
Devices, FDA
TSO3, STERIZONE, Sterilizer

Edwards Announces Board Changes

Tue, 02/10/2015 - 16:17
IRVINE, Calif., Feb. 10, 2015 -- (Healthcare Sales & Marketing Network) -- Edwards Lifesciences Corporation (EW), the global leader in the science of heart valves and hemodynamic monitoring, today announced two changes to the company's board of directors....
Devices, Cardiology, Personnel
Edwards Lifesciences

Biomet Announces Successful Global Introduction of G7 OsseoTi Porous Acetabular Shells

Tue, 02/10/2015 - 16:15
WARSAW, Ind.--(Healthcare Sales & Marketing Network)--Biomet Orthopedics, LLC, a global leader in the manufacture of orthopedic and biotechnology products, today announced regulatory clearance and first clinical use of OsseoTi Porous Technology for total h...
Devices, Orthopaedic, Product Launch
Biomet Orthopedics, total hip, Acetabular shell

Silk Road Medical Announces FDA 510(k) Clearance of the ENROUTE(R) Transcarotid Neuroprotection System

Tue, 02/10/2015 - 16:11
Novel system to protect against stroke via direct carotid access and robust blood flow reversal initiates a new era in carotid revascularization SUNNYVALE, Calif., Feb. 10, 2015 -- (Healthcare Sales & Marketing Network) -- Silk Road Medical, Inc., a pi...
Devices, Interventional, FDA
Silk Road Medical, Transcarotid Neuroprotection System, carotid stent

InVivo Therapeutics Appoints Lorianne Masuoka, MD as Chief Medical Officer

Mon, 02/09/2015 - 15:23
CAMBRIDGE, Mass.--(Healthcare Sales & Marketing Network)--InVivo Therapeutics Holdings Corp. (NVIV) today announced the appointment of Lorianne Masuoka, MD, as Chief Medical Officer (CMO), effective March 2, 2015. She will be taking over for the interim CM...
Devices, Neurology, Personnel
InVivo Therapeutics

PerkinElmer Elects Sylvie Grégoire to its Board of Directors

Mon, 02/09/2015 - 15:20
WALTHAM, Mass.--(Healthcare Sales & Marketing Network)--PerkinElmer, Inc. (PKI), a global leader focused on improving the health and safety of people and the environment, today announced that Sylvie Grégoire, Pharm. D., has been elected to its Board...
Devices, Personnel

Texas Center For Proton Therapy Names Dr. Andrew K. Lee Medical Director

Mon, 02/09/2015 - 15:17
Renowned oncology leader, innovator, and researcher from MD Anderson joins DFW's first proton therapy treatment facility IRVING, Texas, Feb. 9, 2015 -- (Healthcare Sales & Marketing Network) -- Dr. Andrew K. Lee, a renowned leader in oncology and innov...
Devices, Oncology, Personnel
Texas Center For Proton Therapy, proton beam, proton therapy, radiotherapy

Atossa Genetics Signs National Distribution Agreement With Thermo Fisher Scientific for FullCYTE Breast Aspirator

Mon, 02/09/2015 - 15:14
SEATTLE, WA--(Healthcare Sales & Marketing Network) - Atossa Genetics Inc. (NASDAQ: ATOS), the Breast Care Company, has signed an agreement with Thermo Fisher Scientific for distribution of Atossa's FullCYTE Breast Aspirator device in the United States thr...
Diagnostics, Devices, Oncology, Distribution
Atossa Genetics, Thermo Fisher Scientific, FullCYTE, Breast Aspirator

Catabasis Names Rick Modi Chief Business Officer

Fri, 02/06/2015 - 13:57
CAMBRIDGE, Mass.--(Healthcare Sales & Marketing Network)--Catabasis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics using its proprietary SMART linker techn...
Biopharmaceuticals, Personnel
Catabasis Pharmaceuticals

SCYNEXIS Names Marco Taglietti, M.D., Chief Executive Officer

Fri, 02/06/2015 - 13:51
Yves Ribeill, Ph.D., to Remain President, Serve on Board of Directors Carole Sable, M.D., Submits Resignation as Chief Medical Officer RESEARCH TRIANGLE PARK, N.C., Feb. 6, 2015 -- (Healthcare Sales & Marketing Network) -- Drug discovery and develop...
Biopharmaceuticals, Personnel
SCYNEXIS, SCY-078, fungal infection

Sorin Group Receives Regulatory Approval for New Generation MRI Compatible Pacing System in Japan

Fri, 02/06/2015 - 12:54
KORA 100 pacemakers feature Automatic MRI Mode exclusively available in Sorin devices TOKYO--(Healthcare Sales & Marketing Network)--Sorin Group, (Reuters Code: SORN.MI), a global medical device company and a leader in the treatment of cardiovascular di...
Devices, Cardiology, Regulatory
Sorin Group, pacemaker, MRI mode, BEFLEX pacing lead

Roka Bioscience Strengthens Management Team to Drive Growth

Thu, 02/05/2015 - 15:48
WARREN, N.J., Feb. 5, 2015 -- (Healthcare Sales & Marketing Network) -- Roka Bioscience, Inc. (ROKA), a molecular diagnostics company focused on providing advanced testing solutions for the detection of foodborne pathogens, today announced that Mary Dusea...
Diagnostics, Personnel
Roka Bioscience

Vascular Pathways, Inc. Signs New Agreement With Amerinet for AccuCath(R) Line of Catheters

Thu, 02/05/2015 - 15:44
BOCA RATON, FL--(Healthcare Sales & Marketing Network) - Vascular Pathways, Inc., a privately held medical device manufacturer with innovative wire guided technology for peripheral intravascular access, today announced a new agreement with Amerinet, a nati...
Devices, Group Purchasing
Vascular Pathways, Amerinet, AccuCath

Hansen Medical Announces Expanded Protocol for the ARTISAN AF IDE Study

Thu, 02/05/2015 - 15:41
FDA Approves Inclusion of the Latest Technology for the Treatment of Atrial Fibrillation MOUNTAIN VIEW, CA--(Healthcare Sales & Marketing Network) - Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced FDA appr...
Devices, Cardiology, FDA
Hansen Medical, Sensei, Robotic Catheter, atrial fibrillation

First TomoTherapy(R) System in Latin America Dedicated Solely to Breast Cancer Care Now Treating Patients

Wed, 02/04/2015 - 13:50
Advanced Radiation Therapy System Ideally Suited for Efficient, Effective Treatment of Range of Breast Cancer Cases SUNNYVALE, Calif., Feb. 4, 2015 -- (Healthcare Sales & Marketing Network) -- Accuray Incorporated (ARAY) announced today that the first ...
Devices, Radiology, Oncology
Accuray, TomoTherapy, radiotherapy, IMRT, TomoHelical

Third Rock Ventures Launches REVOLUTION Medicines with $45 Million Series A to Redesign Evolution’s Products to Treat Serious Diseases

Wed, 02/04/2015 - 13:44
Company Secures Exclusive License Agreement with University of Illinois SAN FRANCISCO/REDWOOD CITY, Calif.--(Healthcare Sales & Marketing Network)--Third Rock Ventures, LLC today announced the formation of REVOLUTION Medicines, Inc. with a $45 million S...
Biopharmaceuticals, Venture Capital

Concert Pharmaceuticals Announces Appointment of James V. Cassella as Chief Development Officer

Wed, 02/04/2015 - 13:38
LEXINGTON, Mass.--(Healthcare Sales & Marketing Network)--Concert Pharmaceuticals, Inc. (CNCE) today announced that it has appointed James V. Cassella, Ph.D. as Chief Development Officer. In this newly created role, Dr. Cassella will lead Concert’s product...
Biopharmaceuticals, Personnel
Concert Pharmaceuticals

Mazor Robotics Names Sandra Adzic Vice President of International Sales

Wed, 02/04/2015 - 13:32
CAESAREA, Israel--(Healthcare Sales & Marketing Network)--Mazor Robotics Ltd. (TASE:MZOR; NASDAQGM:MZOR), a developer of innovative guidance systems and complementary products, today announced that Sandra Adzic has been named Vice President of Internationa...
Devices, Surgery, Personnel
Mazor Robotics, Renaissance, robotic surgery

Genentech’s Phase III Study of Gazyva(R) Showed Significant Benefit in Refractory Indolent Non-Hodgkin’s Lymphoma

Wed, 02/04/2015 - 13:23
SOUTH SAN FRANCISCO, Calif.--(Healthcare Sales & Marketing Network)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today positive results from the Phase III GADOLIN study, which evaluated treatment options for people with i...
Biopharmaceuticals, Oncology
Genentech, Roche Group, GADOLIN study, Gazyva, obinutuzumab

SpineGuard Receives FDA Clearance to Market Its PediGuard Products for Minimally Invasive Surgery (MIS)

Tue, 02/03/2015 - 20:31
PARIS & SAN FRANCISCO--(Healthcare Sales & Marketing Network)--SpineGuard (FR0011464452 – ALSGD) announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its PediGuard products for Minimally Invasive ...
Devices, Orthopaedic, Neurosurgery, FDA
SpineGuard, PediGuard, pedicle screw

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong